한빛사331건

• • 박지선(가톨릭대학교)

  • 이채현(가톨릭대학교)

    Interview

  • 구희범(가톨릭대학교 의과대학)

  Efficient drug supply in stem cell cytosol via pore-forming saponin nanoparticles promotes in vivo osteogenesis and bone regeneration.

  • Biomaterials Volume 302, November 2023, 122342 | https://doi.org/10.1016/j.biomaterials.2023.122342

  • 2023.11
  • 바이오·의료융합

• • 정희정(Columbia University)

  Genetic Modification of Acidithiobacillus ferrooxidans for Rare-Earth Element Recovery under Acidic Conditions

  • Environ. Sci. Technol. Nov 20 2023, | https://doi.org/10.1021/acs.est.3c05772

  • 2023.11

• • 서가영(University of california, Irvine)

  MAP4K2 connects the Hippo pathway to autophagy in response to energy stress

  • Autophagy Nov 08 2023, | https://doi.org/10.1080/15548627.2023.2280876

  • 2023.11

• • 김도균(Cleveland Clinic)

  • 최윤호(Cleveland Clinic)

  • 정재웅(Cleveland Clinic)

  SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge

  • J. Med. Virol. Nov 2023, 95 (11) | https://doi.org/10.1002/jmv.29203

  • 2023.11
  • 의약학

• • 김보라(The University of Texas Health Science Center at Houston)

  FusionNeoAntigen: a resource of fusion gene-specific neoantigens

  • Nucleic Acids Res. 2023 Oct 23:gkad922 | https://doi.org/10.1093/nar/gkad922

  • 2023.10
  • 바이오·의료융합

• • 복서연(Weill Cornell Medicine)

  A multi-stem cell basis for craniosynostosis and calvarial mineralization

  • Nature 20 September 2023 | https://doi.org/10.1038/s41586-023-06526-2

  • 2023.09
  • 생명과학

• • 이시선(KRIBB, UST)

  • 강민식(KRIBB, UST)

  • 성봉현(KRIBB, UST, KAIST)

  Development of novel recombinant peroxidase secretion system from Pseudomonas putida for lignin valorisation.

  • Bioresour. Technol. Sep 20 2023, S0960-8524(23)01207-5 | https://doi.org/10.1016/j.biortech.2023.129779

  • 2023.09

• • 김서연(서울대학교)

  • 이해인(서울대학교)

  • 박태현(서울대학교, 이화여자대학교)

  • 황석연(서울대학교)

  Bone-Targeted Delivery of Cell-Penetrating-RUNX2 Fusion Protein in Osteoporosis Model

  • Adv. Sci. 2023 Aug 13;e2301570 | https://doi.org/10.1002/advs.202301570

  • 2023.08
  • 바이오·의료융합

• • 조병철(연세대학교 의과대학)

  Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, PD-L1-high advanced non-small cell lung cancer: a randomized, open-label, phase

  • J. Thorac. Oncol. Aug 17 2023, S1556-0864(23)00738-4 | https://doi.org/10.1016/j.jtho.2023.08.018

  • 2023.08
  • 의약학

• • 조희연(Keck School of Medicine, Biola University)

  Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate

  • Autophagy 2023 Aug 6;1-20 | https://doi.org/10.1080/15548627.2023.2242696

  • 2023.08

• • 오준용(UNIST)

  • 안은경(울산대학교 의과대학)

  • 최은실(UNIST)

  • 진준오(울산대학교 의과대학, 서울아산병원)

  • 유자형(UNIST)

  Antibody Plug-and-Playable Nanoparticles as a facile and versatile platform for targeted drug delivery

  • Chem. Eng. J. Volume 470, 15 August 2023 | https://doi.org/10.1016/j.cej.2023.144357

  • 2023.08
  • 바이오·의료융합

• • David S. Hong(The University of Texas MD Anderson Cancer Center)

  Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

  • Nat. Med. Published: 27 July 2023 | https://doi.org/10.1038/s41591-023-02452-y

  • 2023.07

• • 박미순(University of T?bingen)

  NSF/αSNAP2-mediated cis-SNARE complex disassembly precedes vesicle fusion in Arabidopsis cytokinesis

  • Nat. Plants 01 June 2023 | https://doi.org/10.1038/s41477-023-01427-8

  • 2023.06

• • 이평세(Harvard Medical School / UC Berkeley)

  Bioinspired engineering of fusogen and targeting moiety equipped nanovesicles

  • Nat. Commun. 2023 Jun 8;14(1):336 | https://doi.org/10.1038/s41467-023-39181-2

  • 2023.06
  • 바이오·의료융합

• • 손수민(한국생명공학연구원)

  • 안수빈(한국화학연구원, 충남대학교)

  • 김미현(한국화학연구원, 충남대학교)

  • 김상직(한국생명공학연구원)

  Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice

  • Antiviral Res. 2023 May;213:105591 | http://dx.doi.org/10.1016/j.antiviral.2023.105591

  • 2023.05
  • 생명과학

• • 윤석현(Harvard Medical School and Massachusetts General Hospital)

  All-natural-molecule, bioluminescent photodynamic therapy results in complete tumor regression and prevents metastasis

  • Biomaterials 2023 May;296:122079 | https://doi.org/10.1016/j.biomaterials.2023.122079

  • 2023.05

• • 김용환(고려대학교)

    Interview

  • 이동택(Harvard Medical School)

  • 이상원(고려대학교)

  • 이정훈(광운대학교)

  • 윤대성(고려대학교)

  Caco-2 cell-derived biomimetic electrochemical biosensor for cholera toxin detection

  • Biosens. Bioelectron. 2023 Apr 15;226:115105 | https://doi.org/10.1016/j.bios.2023.115105

  • 2023.04
  • 바이오·의료융합

• • 장은홍(GIST)

  • 문여진(GIST)

  • 전영수(GIST)

  Human atlastins are sufficient to drive the fusion of liposomes with a physiological lipid composition

  • J. Cell Biol. 2023 Apr 3;222(4):e202109090 | https://doi.org/10.1083/jcb.202109090

  • 2023.04
  • 생명과학

• • 이경(University of Washington and Fred Hutchinson Cancer Research Center)

  Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy

  • Nat. Commun. Published: 11 April 2023 | https://doi.org/10.1038/s41467-023-37874-2

  • 2023.04

• • 나상준(KAIST)

  • 김세기(KAIST)

  • 김찬혁(KAIST)

  Engineering second-generation TCR-T cells by site-specific integration of TRAF-binding motifs into the CD247 locus

  • J. Immunother. Cancer 2023 Apr;11(4):e005519 | http://dx.doi.org/10.1136/jitc-2022-005519

  • 2023.04
  • 바이오·의료융합